We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-13.92%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.18B
AUM Growth
-$341M
Cap. Flow
+$97.4M
Cap. Flow %
4.47%
Top 10 Hldgs %
35.92%
Holding
3,540
New
358
Increased
1,256
Reduced
1,110
Closed
245

Sector Composition

Rank Sector Weight
1 Technology 12.72%
2 Financials 8.76%
3 Healthcare 8.32%
4 Communication Services 4.17%
5 Consumer Discretionary 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONB icon
1726
Old National Bancorp
ONB
$10.1B
$17K ﹤0.01%
1,139
+1,043
+1,086% +$16.1K
PHT
1727
DELISTED
Pioneer High Income Fund
PHT
$17K ﹤0.01%
2,419
PPA icon
1728
Invesco Aerospace & Defense ETF
PPA
$8.72B
$17K ﹤0.01%
240
ROG icon
1729
Rogers Corp
ROG
$2.29B
$17K ﹤0.01%
64
-6
-9% -$1.6K
UBSI icon
1730
United Bankshares
UBSI
$6.55B
$17K ﹤0.01%
480
-154
-24% -$5.4K
VGLT icon
1731
Vanguard Long-Term Treasury ETF
VGLT
$10.3B
$17K ﹤0.01%
237
W icon
1732
Wayfair
W
$14.1B
$17K ﹤0.01%
394
+125
+46% +$8.79K
WBS icon
1733
Webster Financial
WBS
$12.8B
$17K ﹤0.01%
400
-85
-18% -$4.09K
WIX icon
1734
WIX.com
WIX
$2.61B
$17K ﹤0.01%
264
-56
-18% -$4.1K
WTS icon
1735
Watts Water Technologies
WTS
$12.8B
$17K ﹤0.01%
141
-19
-12% -$2.47K
XRT icon
1736
State Street SPDR S&P Retail ETF
XRT
$652M
$17K ﹤0.01%
295
+2
+0.7% +$136
TFFP
1737
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$17K ﹤0.01%
119
ATCO
1738
DELISTED
Atlas Corp.
ATCO
$17K ﹤0.01%
1,551
AAL icon
1739
American Airlines Group
AAL
$9.93B
$16K ﹤0.01%
1,269
-89
-7% -$1.48K
AEVA
1740
Aeva Technologies
AEVA
$1.65B
$16K ﹤0.01%
1,000
ARI
1741
Apollo Commercial Real Estate
ARI
$871M
$16K ﹤0.01%
1,521
-1
-0.1% -$12
AROC icon
1742
Archrock
AROC
$5.81B
$16K ﹤0.01%
1,991
-13
-0.6% -$119
CLB icon
1743
Core Laboratories
CLB
$561M
$16K ﹤0.01%
802
-149
-16% -$3.96K
CSL icon
1744
Carlisle Companies
CSL
$15.3B
$16K ﹤0.01%
65
+8
+14% +$1.99K
DNA icon
1745
Ginkgo Bioworks
DNA
$515M
$16K ﹤0.01%
+170
New +$20.7K
DVAX
1746
DELISTED
Dynavax Technologies
DVAX
$16K ﹤0.01%
1,250
FELE icon
1747
Franklin Electric
FELE
$4.75B
$16K ﹤0.01%
221
-30
-12% -$2.23K
FWRD icon
1748
Forward Air
FWRD
$634M
$16K ﹤0.01%
175
+33
+23% +$3.06K
GH icon
1749
Guardant Health
GH
$22.4B
$16K ﹤0.01%
390
-4
-1% -$198
GII icon
1750
State Street SPDR S&P Global Infrastructure ETF
GII
$929M
$16K ﹤0.01%
300

Similar funds

Parallel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Parallel Advisors held 3,540 positions worth $2.18B, down 14% from $2.52B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parallel Advisors deployed $97.4M of net new capital in Q2 2022, opening 358 new positions and adding to 1,256 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 26,194 shares worth $828K.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI USA Value Factor ETF, an estimated $20.7M trimmed.

  • Parallel Advisors's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 26,194 shares worth $828K.
  • Parallel Advisors added most to Schwab US Dividend Equity ETF in Q2 2022, an estimated $39.1M increase.
  • Parallel Advisors's biggest Q2 2022 reduction was iShares MSCI USA Value Factor ETF, cutting an estimated $20.7M.
  • Parallel Advisors fully exited ZYNGA INC. CL A COMMON in Q2 2022, selling an estimated $7.79M.
  • Parallel Advisors's ten largest holdings make up 36% of its $2.18B portfolio in Q2 2022.
  • Parallel Advisors opened 358 new positions and closed 245 in Q2 2022.
  • Parallel Advisors's portfolio value fell 14% quarter-over-quarter to $2.18B.

Based on Parallel Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.